Learn About Genomics and Epigenetics & Save!

Posted by ISPE Boston
On April 25, 2018

No current medical development raises so many opportunities – ranging from cancer treatment, to degenerative disease, to aging itself. To learn more, join the Medical Development Group (MDG) on Monday, April 30 at Regis College Fine Arts Center in Weston, MA for their program “Genomics and epi-Genetics – Impact on Developments in Medicine and Society.” […]

Reap Rewards as a Chapter Volunteer

Posted by ISPE Boston
On April 24, 2018

We’ve just made it easier for members to join the team of Boston Area Chapter volunteers. Becoming a volunteer enables you to build relationships with other Chapter members and helps you grow personally and professionally. All while helping the Chapter accomplish its goals. And to make it even easier for you to contribute your talents […]

Chapter Members: Local ISPE Training at a Discount Just for You

Posted by ISPE Boston
On April 19, 2018

Take advantage of a rare opportunity – four full days of ISPE biopharma training in the Boston area May 7-10 plus a 20 percent discount for members of the Boston Area Chapter! Enjoy specialized, in-depth classroom trainings from leading industry experts in seven critical areas: Biopharmaceutical Manufacturing Facility Design and Processes, GAMP® 5 Basic Principles […]

BioReady Communities Well-Positioned to Support Life Sciences Growth in MA

Posted by ISPE Boston
On April 16, 2018

The BioReady Community designation from Massachusetts Biotechnology Council (MassBio) signifies that a municipality has biotech and life sciences friendly zoning, has a streamlined permitting process, and has robust infrastructure in place. The designation serves to showcase Massachusetts communities that are ready to host new life sciences research and manufacturing facilities. There are currently 84 BioReady […]

Novartis to Acquire AveXis, Expand Position in Gene Therapy

Posted by ISPE Boston
On April 16, 2018

Novartis has announced that it has entered into an agreement to acquire the Illinois-based clinical stage gene therapy company AveXis, Inc. for $218 per share or a total of $8.7 billion in cash. AveXis has several clinical studies in progress for the treatment of SMA, an inherited neurodegenerative disease caused by a defect in a […]

Amgen’s Next-Generation Biomanufacturing Plant Heads for Rhode Island

Posted by ISPE Boston
On April 10, 2018

Amgen today announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its campus in West Greenwich, R.I. The new plant, the first of its kind in the U.S., will employ Amgen’s proven next-generation biomanufacturing capabilities and manufacture products for the U.S. and global markets. A next-generation biomanufacturing plant incorporates multiple innovative technologies into […]

Scholarship Applications Due June 1, 2018

Posted by ISPE Boston
On April 10, 2018

The ISPE Boston Area Chapter Scholarship Foundation is proud to offer a merit-based scholarship program honoring Joel Goldenberg, Past President of the Boston Area Chapter. The Scholarship Foundation is supported by charitable contributions from the Boston Area Chapter and others, and has awarded 105 scholarships to date, totaling over $125K. Individual awards of up to […]

Chapter Member Anniversaries: March 2018

Posted by ISPE Boston
On April 4, 2018

Please congratulate the following members celebrating milestone anniversaries in March 2018. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Saboo Aghababayan, MS, MBA, Genzyme Corp Stanley O. Berg, BSEE, Aubena Inc Sean M. Brown, Barry-Wehmiller Design Group John R. Butterfield, Hallam Associates Inc Richard F. Caires, Jr., […]

Welcome New Members!

Posted by ISPE Boston
On April 4, 2018

We would like to introduce the members who joined ISPE in March 2018, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

Foghorn Therapeutics to Target Gene Expression with $50Million

Posted by ISPE Boston
On March 22, 2018

Flagship Pioneering has unveiled Foghorn Therapeutics, a unique life science innovation enterprise that uses its proprietary Gene Traffic Control product platform to discover and develop drugs based on novel insights into the chromatin regulatory system which directs gene expression in cells. Flagship Pioneering developed and launched Foghorn Therapeutics through its innovation foundry, Flagship VentureLabs, and […]

Page 83 of 90«‹81 828384 85 ›»